Related Experiment Video
Updated: Mar 11, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Prepregnancy obesity and the racial disparity in infant mortality
Lara S Lemon1,2,3, Ashley I Naimi1, Barbara Abrams4
1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania, USA.
Insights
Prepregnancy obesity contributes to the Black-White disparity in stillbirth and infant mortality. Addressing obesity could reduce these adverse birth outcomes for Black women.
Area of Science:
- Reproductive Health
- Perinatal Epidemiology
- Public Health
Background:
- Significant racial disparities exist in stillbirth and infant mortality rates in the United States.
- Non-Hispanic Black women experience disproportionately higher rates of these adverse outcomes compared to non-Hispanic White women.
Purpose of the Study:
- To quantify the extent to which prepregnancy obesity explains the Black-White disparity in stillbirth and infant mortality.
- To assess the impact of prepregnancy obesity on racial differences in adverse pregnancy outcomes.
Main Methods:
- A population-based study utilized linked birth and infant death certificates in Pennsylvania from 2003-2011 and fetal death certificates from 2006-2011.
- Included singleton pregnancies of non-Hispanic White and non-Hispanic Black women.
- Inverse probability weighted regression analysis was employed to estimate the role of prepregnancy obesity.
Main Results:
- Non-Hispanic Black women had higher rates of obesity, stillbirth, and infant death compared to non-Hispanic White women.
- Removing the contribution of prepregnancy obesity reduced the risk difference for stillbirth and infant death between the two racial groups.
- Prepregnancy obesity accounted for a notable proportion of excess infant deaths and stillbirths among non-Hispanic Black women.
Conclusions:
- Prepregnancy obesity is a significant, though not sole, contributor to the Black-White disparity in stillbirth and infant mortality.
- Interventions targeting prepregnancy obesity may help mitigate racial disparities in adverse perinatal outcomes.
- Reducing prepregnancy obesity among Black women could lead to a decrease in excess infant deaths and stillbirths.
Objective:
To estimate the extent to which prepregnancy obesity explains the Black-White disparity in stillbirth and infant mortality.
Methods:
A population-based study of linked Pennsylvania birth-infant death certificates (2003-2011; n = 1,055,359 births) and fetal death certificates (2006-2011; n = 3,102 stillbirths) for all singleton pregnancies in non-Hispanic (NH) White and NH Black women was conducted. Inverse probability weighted regression was used to estimate the role of prepregnancy obesity in explaining the race-infant/fetal death association.
Results:
Compared with NH White women, NH Black women were more likely to have obesity (≥30 kg/m2 ) and experienced a higher rate of stillbirth (8.3 vs. 3.6 stillbirths per 1,000 live-born and stillborn infants) and infant death (8.5 vs. 3.0 infant deaths per 1,000 live births). When the contribution of prepregnancy obesity was removed, the difference in risk between NH Blacks and NH Whites decreased from 6.2 (95% CI: 5.6-6.7) to 5.5 (95% CI: 4.9-6.2) excess stillbirths per 1,000 and 5.8 (95% CI: 5.3-6.3) to 5.2 (95% CI: 4.7-5.7) excess infant deaths per 1,000.
Conclusions:
For every 10,000 live births in Pennsylvania (2003-2011), 6 of the 61 excess infant deaths in NH Black women and 5 of the 44 excess stillbirths (2006-2011) were attributable to prepregnancy obesity.
More Related Videos
Related Concept Videos
Regression Toward the Mean
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

